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Abstract
Background: Bacteriocins are peptide-derived molecules produced by bacteria, whose recently-discovered
functions include virulence factors and signaling molecules as well as their better known roles as antibiotics. To date,
close to five hundred bacteriocins have been identified and classified. Recent discoveries have shown that
bacteriocins are highly diverse and widely distributed among bacterial species. Given the heterogeneity of bacteriocin
compounds, many tools struggle with identifying novel bacteriocins due to their vast sequence and structural
diversity. Many bacteriocins undergo post-translational processing or modifications necessary for the biosynthesis of
the final mature form. Enzymatic modification of bacteriocins as well as their export is achieved by proteins whose
genes are often located in a discrete gene cluster proximal to the bacteriocin precursor gene, referred to as context
genes in this study. Although bacteriocins themselves are structurally diverse, context genes have been shown to be
largely conserved across unrelated species.
Methods: Using this knowledge, we set out to identify new candidates for context genes which may clarify how
bacteriocins are synthesized, and identify new candidates for bacteriocins that bear no sequence similarity to known
toxins. To achieve these goals, we have developed a software tool, Bacteriocin Operon and gene block Associator
(BOA) that can identify homologous bacteriocin associated gene blocks and predict novel ones. BOA generates
profile Hidden Markov Models from the clusters of bacteriocin context genes, and uses them to identify novel
bacteriocin gene blocks and operons.
Results and conclusions: We provide a novel dataset of predicted bacteriocins and context genes. We also discover
that several phyla have a strong preference for bacteriocin genes, suggesting distinct functions for this group of
molecules.
Software Availability: https://github.com/idoerg/BOA
Keywords: Bacteriocins, Operons, Microbiology, Gene blocks
Background
Natural Product discovery has been a cornerstone of
many pharmaceuticals and therapeutics. It is estimated
that about 80% of all drugs are either natural prod-
ucts or derived analogs [1]. These compounds encompass
antibiotics (penicillin, tetracycline, erythromycin), anti-
infectives (avermectin, quinine, artemisinin), pharmaceu-
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ticals (lovastatin, cyclosporine, rapamycin) and anticancer
drugs (taxol, doxorubicin) [2]. Yet, despite this long his-
tory of success, pharmaceutical efforts in natural products
research has decreased steadily between 2001 and 2008
[3]. Financial pressure from drug companies as well as
difficulties in isolation and identification of natural com-
pounds have severely limited the discovery rate of these
important sources.
Bacteriocins are a large class of peptide-based antibi-
otics that encompass an extraordinary amount of chemi-
cal, structural, and functional diversity [4]. The structures
of these compounds have revealed that a large number
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comprise a class of highly modified polypeptides. Inter-
estingly, many bacteriocins are synthesized ribosomally as
precursor peptides and are subsequently modified post-
translationally to yield their biologically active forms.
Post-translational modification serves to confer specific
chemical properties that could not be obtained by peptide
synthesis alone. Furthermore, post-translational modi-
fications can be used as a mechanism to control the
activation of the toxic activities of the bacteriocin, and
thus exert a level of control and host immunity [5].
Genome mining has been an important technolog-
ical resource in the discovery of novel natural prod-
ucts, including bacteriocins. Bacteriocin-like peptides are
highly attractive candidates for genome mining, as these
natural products are genetically encoded with nearby
genes encoding their corresponding modifying enzymes.
Proximity to genes encoding known modifying enzymes
can often aid in the identification of peptide biosynthe-
sis gene clusters [6]. In many cases, several metabolites
have been identified from “cryptic” or “orphan gene clus-
ters” [7]. These cryptic gene clusters have demonstrated
that new, as yet uncharacterized enzymology is likely to
be involved in the assembly of the final natural product,
likely leading to a greater diversity of bacterial peptides
than previously appreciated.
Several web-based gene mining and annotation tools
have been developed to aid in the identification, charac-
terization, and classification of novel bacteriocins. These
include mining tools such as BAGEL [8] and bacteriocin
repositories such as BACTIBASE [9]. Anti-SMASH is a
recently developed website that expands genome mining
to not only bacteriocins but a host of other genetically-
identifiable antibiotics and other secondary metabolites
[10] Although genemining resources such as BAGEL have
existed formany years, onemajor limitation in bacteriocin
gene mining that is becoming evident as more bacteri-
ocins are identified is the lack of homology in the genes
encoding the actual precursor peptides for bacteriocins.
Detecting novel bacteriocin producing genes through
bioinformatic methods focused on precursor peptide dis-
covery therefore remains a significant challenge.
The bacteriocins’ structure and sequence diversity make
them difficult to detect using sequence homology algo-
rithms such as BLAST [11]. In addition, their short
sequence length makes them difficult to detect with
ORF calling tools. Programs such as BAGEL have made
great strides in identifying bacteriocins by searching
for well-defined conserved motifs within the bacteri-
ocin toxin sequences and adjacent context genes using
Pfam databases [8]. However, the number of hypotheti-
cal bacteriocin genes that can be identified using such a
method is highly limiting as these motifs are not neces-
sarily known or conserved. Given that bacteriocin genes
are highly diverse, it is likely that mining genomes for
potential bacteriocin genes using sequence or profile sim-
ilarity are likely to miss a large number of as-yet identified
bacteriocin compounds.
Genes that encode bacteriocin precursors are often
proximal in genomic sequence to accessory genes that
are required to modify and secrete the bacteriocin pep-
tide. These co-located gene blocks often contain genes
that encode enzymes which perform post-translational
modification and maturation of the bacteriocin prod-
uct. Additionally, many of these gene blocks contain
genes encoding various transporter proteins, presum-
ably linked to specific export of the mature bacteriocin.
Unlike the bacteriocin genes, these context genes are
conserved across taxa, as they belong to conserved fam-
ilies of enzymes and other modifying proteins, as well
as to transporters such as ATP-binding cassette (ABC)
family of transporters. In the case of the large family
of thiazole and oxazole modified bacteriocins, such as
Microcin B17 and Streptolysin S, each gene block shares
both conserved modification proteins as well as transport
machinery genes that are located close to the bacteriocin
gene [6, 12].
Here we present a new methodology that takes advan-
tage of the conservation of context genes to identify loca-
tions of gene blocks associated with bacteriocins. Our
approach is to identify context genes in addition to toxin
genes without restricting our tool to finding homologs
in annotated databases. To the best of our knowledge,
there is no available public database that contains the
complete bacteriocin gene clusters and their associated
context genes. Therefore, BOA is useful for the construc-
tion of such a tool as well as for mining genomes for
putative bacteriocins. We provide bacteriocin gene block
predictions for 2773 genomes, in which the bacteriocin
gene blocks may be browsed. The method is implemented
as a software tool named Bacteriocin Operon and gene
block Associator (BOA).
Methods
We used the bacterial and archaeal genome files from
GenBank 2014 [13] for our dataset. Since we are interested
in identifying bacteriocin associated gene clusters, we did
not analyze partial contig files, and only whole bacterial
chromosomes and plasmids were analyzed. Bacteriocins
identified by BAGEL3 and seven experimentally identified
bacteriocin associated gene blocks were used as a stan-
dard of truth or a “gold standard” data set. All of the con-
text genes within these gene blocks were placed into five
functional categories toxins, modifiers, immunity, trans-
port, and regulation. Toxin genes refer to the open reading
frames encoding the toxin precursor peptide; modifiers
perform post-translational modification to the protoxin,
and can include enzymes which are involved in amino acid
modification (cyclodehydration, lanthionine synthesis, as
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well as leader peptide processing enzymes); immunity
genes that prevent the toxin from affecting the host bac-
terial cells; transport genes create transporter proteins to
move the toxin outside of the cell, and regulator genes
control the expression of toxin proteins and other genes in
the operon [6].
An overview of the pipeline is shown in Fig. 1. The
method in detail is as follows:
1. Construct a set of experimentally-verified context
genes. This we call the Literature Curated Set. The
LC Set includes seven known bacteriocin associated
gene blocks. The known gene blocks comprised
enterococcal cytolysin and enterocin AS-48 from
Enterococcus faecalis, microcin J25 from Escherichia
coli, Nisin A from Lactococcus lactis subsp. lactis,
streptolysin S and salivaricin A from Streptococcus
pyogenes, and thiocillin from Bacillus cereus
[14–20]. These blocks are representative of several
important classes of bacteriocins, namely lantibiotics
(enterococcal cytolysin, Nisin A, salivaricin A),
thiopeptides (thiocillin), thiazole/oxazole-modified
microcins (TOMMs; streptolysin S), lassoed tail
peptides (microcin J25), and circular bacteriocins
(enterocin AS-48). While bacteriocin biosynthetic
gene blocks are widely distributed among prokarya,
Fig. 1 An overview of the BOA Pipeline. The stages in the pipeline are elaborated upon in the ‘Methods’ section. (1): construction of the LC-Set and
the BAGEL set; (2) BLAST LC and BAGEL genes against all bacterial & archaeal genomes evalue=10−5; (3) select the ORFs within ±50 kb of homologs
to toxin genes (4) assign ORFs to one of the following classes (left to right): toxin, modifier, immunity, transport, regulation; (5) build pHMMs from
each category: cluster sequences using CD-HIT, align sequences in each cluster using MAFFT, then use hmmbuild from the HMMER suite to
construct HMMs; (6) run hmmsearch from the HMMER suite against the genome files to extract more sequences from each category, remove
predicted false positives using a threshold score as explained in Methods (7) use a clique filter to identify genes that are close together
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Fig. 2 Determining the threshold for similarity-based search of toxin
genes. Toxin gene candidates were derived as described in the text.
To determine an adequate threshold for inferring homology, we
examined the distribution of HMMER scores for homologs for
predicted toxin genes (red) and BAGEL-derived toxin genes (blue).
BAGEL toxin gene scores were used to set a minimum threshold of
acceptance for HMMER scores for predicted genes
the major structurally-related groups are few and
their relevant context genes are largely represented
in the LC Set. The genes were categorized as toxins,
modifiers, immunity, transport, or regulation. The
genes making up the LC Set are available in the
supplemental material.
2. BLAST the LC Set genes and the BAGEL toxin genes
against the bacterial genome set.
3. Select ORFs with (a) e-value < 10−5 and (b) within
± 50 kb of the homologs to the toxin genes (whether
from the LC set or the BAGEL set).
4. Assign each homologous ORF according to the
category of the gene to which it is found to be
similar: toxin, modifier, immunity, transport, or
regulation. Ambiguities are resolved by taking the
best hit based on the BLAST E-value.
5. Build profile HMMs: cluster the sequences in each
bin independently using CD-HIT [21], then use
MAFFT [22] to perform a multiple alignment in each
homology cluster, and HMMER [23] to build
pHMMs from the multiple alignments.
6. Run the resulting pHMM’s against the bacterial
genome files. Since most of the HMMER hits are
probably false positives, we set a score threshold to
filter them out. We determined this threshold by
obtaining HMMER scores for all of the BAGEL
bacteriocins found on the bacterial genomes and
choosing the lowest BAGEL score as the threshold.
See Fig. 2
7. Use a clique filter (see below) to identify those genes
that are close together and therefore candidates for
bacteriocin gene blocks. See Fig. 3.
To identify gene blocks that are candidates for bacte-
riocin biosynthesis, we used a clique filter. A clique is a
complete subgraph where any two nodes are connected
by an edge. We created graphs from the ±50 kb regions
where genes are represented by nodes and for every pair
of genes that are within 25 kb of each other, an edge
is created between them. The detected cliques are esti-
mated gene blocks such that all of the genes are within
25 kb of each other. This 25 kb threshold was based
on the size of known bacteriocin gene clusters given in
our gold standard data set. Figure 3 illustrates the use
of the clique filter to identify potential bacteriocin gene
blocks.
A major challenge in finding toxin genes is that due to
the short length and low complexity of these peptides,
many genes will be missed because of ORF calling errors
or lack of similarity to known toxin genes. To overcome
Fig. 3 Using a clique filter to identify putative bacteriocin gene blocks. Drawing is not to scale, and other genes may exist in between those shown.
a, b and c are all cliques formed from these genes. Clique a has an identifiable homolog to a known toxin, and is considered a viable candidate for a
toxin gene block. Clique b does not have all necessary functions, and therefore is not considered to be a candidate. Clique c contains all necessary
functions and therefore is considered a candidate for a bacteriocin gene block or operon even though there is no homology-detected toxin gene
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Fig. 4 95% (457 out of 479) of BAGEL toxins were predicted by BOA.
BOA predicted an additional 1003 toxins throughout bacterial
genomes that are not listed in BAGEL. Twenty-two BAGEL toxins were
not predicted by BOA
this problem, we organized all detected cliques into gene
blocks with homologs to known toxin genes and gene
blocks without known toxin genes. Cliques with known
toxin genes are required to have at least one toxin gene
and one transport gene. Cliques without any known toxin
genes are required to have at least one of each of a modi-
fier, transport, immunity, and regulator genes. In this way,
we ensure that the cliques we identify have the needed
components to present a putative bacteriocin biosynthetic
locus, and the toxin gene can later be searched using less
restrictive procedures.
Results and Discussion
The many characterized bacteriocins have seldom been
experimentally validated in parallel in the multiple species
which putatively code for their production, restricting our
standard-of-truth data set to a small group of well-studied
bacteriocins relative to the large number of organisms that
produce them. In addition, estimating the false positive
rate is difficult, requiring excessive de novo experimental
validation. Therefore, to evaluate BOA’s performance, we
compared the bacteriocins that we have found to BAGEL
bacteriocins found in bacterial genomes.
Table 1 Number of gene blocks detected by BAGEL and BOA
Item Quantity
BAGEL Toxins 479
Gene blocks predicted by BOA with toxin genes 1003
Gene blocks predicted by BOA without toxin genes 83
Fig. 5 Gene blocks were classified by the number of detected
functions. a number of total genes found; b gene counts per
detected block
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Table 2 Bacterial species with the highest number of BOA-detected gene blocks
Name Genbank ID # Gene Blocks Immunity Modifier Regulator Toxin Transport
Streptococcus equi subsp. zooepi-
demicus MGCS10565
CP001129.1 6 6 8 0 9 11
Streptomyces griseus subsp. griseus
NBRC 13350
AP009493.1 6 0 0 0 8 14
Leifsonia xyli subsp. xyli str.
CTCB07
AE016822.1 5 0 0 0 7 8
Pusillimonas sp. T7-7 CP002663.1 4 1 0 0 6 8
Rhodospirillum rubrum F11 CP003046.1 4 0 0 0 4 4
Streptococcus salivarius CCHSS3 FR873481.1 4 5 1 0 4 5
Streptomyces sp. PAMC26508 CP003990.1 4 0 0 0 4 4
Streptomyces pratensis ATCC
33331
CP002475.1 4 0 0 0 4 5
Symbiobacterium thermophilum
IAM 14863
AP006840.1 4 0 0 1 4 5
Thermotoga neapolitana DSM
4359
CP000916.1 4 5 0 3 4 6
To compare BOA against BAGEL, the toxins shared
between BOA and BAGEL were identified using BLAST
using the default parameters. As shown in Fig. 4 and
Table 1, BOA only missed 22 (5%) bacteriocins that
BAGEL detected, while predicting 457 (95%) in agree-
ment with BAGEL. In addition, BOA was able to pre-
dict over 1003 more putative bacteriocins on bacterial
genomes than BAGEL. In addition, BOA identified 83
regions that are highly likely to be associated with bacteri-
ocin production.
The detected gene blocks were classified into five
groups: (1) gene blocks with all five functional classes
(toxin, modifier, immunity, regulator, transport), (2) gene
blocks with only four functions, (3) three functions,
(4) two functions, and (5) unknown toxins. Figure 5 shows
these findings.
Previously it has been established that every bacteriocin
locus needs at minimum a toxin gene and an immunity
gene [24]. The gene blocks in the first four groups in Fig. 5
have at least one toxin and one transport gene. The final
group of gene blocks do not have any identified bacteri-
ocin genes, but each detected gene block is required to
have all of the other genes. This final group contains likely
candidates for bacteriocin-associated gene blocks that do
not yet have a known, identified bacteriocin. From these
findings, it is evident that genes categorized as transport
genes were identified to be the most common type of
context gene.
Interestingly, the three species harboring the greatest
number of predicted bacteriocin-associated gene blocks
in our screen inhabit different ecological niches (Table 2).
Streptococcus equi subsp. zooepidemicus is a common
colonizer of the respiratory tract with the capacity for
opportunistic infection in a variety of domesticated ani-
mals and sometimes severe infections in humans follow-
ing zoonotic transmission [25]. Streptomyces griseus is a
Table 3 Mean counts per gene block over all phyla that have more than 5 genomes
Phylum Immunity Modifier Regulator Toxin Transport # Genomes
Thermotogae 0.8 0 0.2 1.4 1.8 5
Proteobacteria 0.17 0.05 0.03 1.29 1.47 512
Cyanobacteria 0.13 0.13 0.0968 1.806 1.548 31
Deinococcus-Thermus 0 0 0.333 2 2.667 8
Euryarchaeota 0.5 0 0 0.75 1 6
Actinobacteria 0.337 0.045 0.067 1.708 2.168 89
Spirochaetes 0.06 0.06 0 1.151 1.424 33
Crenarchaeota 1 0 0 1 1 5
Firmicutes 1.182 0.578 0.399 1.594 2.059 318
Bacteroidetes 0.12 0 0 1.24 1.28 25
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Table 4 Mean counts per gene block over all classes that have more than 10 genomes
Class Immunity Modifier Regulator Toxin Transport # Genomes
Spirochaetales 0.06 0.06 0 1.15 1.42 33
Actinobacteridae 0.32 0.05 0.07 1.72 2.17 86
Gammaproteobacteria 0.21 0.04 0.04 1.31 1.58 244
Epsilonproteobacteria 0.19 0 0.05 1.09 1.05 21
Bacilli 1.25 0.77 0.48 1.62 2.15 232
Betaproteobacteria 0.07 0.09 0.05 1.41 1.56 114
Clostridia 1 0.06 0.19 1.53 1.82 84
Alphaproteobacteria 0.16 0.045 0.02 1.18 1.22 110
Oscillatoriophycideae 0.09 0.14 0.09 1.90 1.54 22
soil-dwelling bacterium that has been studied and utilized
in the biotechnology industry for production of numerous
secondary metabolites including the first aminoglycoside
antibiotic, streptomycin [26]. Finally, Leifsonia xyli is a
pathogenic obligate colonizer of the xylem of host plants,
causing economically damaging ratoon stunting disease
in sugarcane [27]. The radically different environments in
which these bacteria reside suggest that predicted bac-
teriocins must have distinct functions, specific organism
targets, or both. Likewise, functional validation and char-
acterization of these kinds of predicted bacteriocins must
take into account the niche in which its producing organ-
ism resides, probing functionalities that target ecologically
relevant target organisms.
Among the gene blocks identified by BOA was
the recently described and experimentally characterized
caynothecamide biosynthetic locus of Cyanothece sp. PCC
7425 (GenBank: CP001344.1) [28]. This gene block, part
of the patellamide family, has nine predicted precur-
sor peptide ORFs with conserved N-termini and diver-
gent C-termini likely resulting from repeated precursor
duplication and divergence. Other bacteriocin clusters
have been described with only one precursor peptide
duplication, and such examples may represent an early
step toward the substrate elaboration displayed by the
cyanothecamides [29]. Interestingly, most of the cyan-
othecamide putative precursors lack the canonical pen-
tapeptide motif required for patellamide maturation, sug-
gesting that inclusion of these sequences in the BOA
gold standard set could expand the set of identified
putative toxin genes to include other non-canonical sub-
strates. Only two of the nine cyanothecamide puta-
tive toxin genes have been experimentally implicated as
precursors to identifiable mature patellamide-like com-
pounds [30]. Yet, the capacity for biosynthetic machinery
to modify substrate peptides with suitable N-terminal
domains despite drastic variability in the C-terminal por-
tion of the peptide has been demonstrated in other
bacteriocins [31, 32]. The features of this particular
gene block raise the possibility that bacteriocin loci
encoding post-translationally modified peptides could,
through elaboration of sequence diversity in multiple cog-
nate peptide substrates, confer a greater breadth of func-
tional diversity to producing organisms than previously
appreciated [33].
Within the genome of the important human pathogen
Group A Streptococcus from which two members of
our gold standard set were obtained (Streptolysin S and
Salivaricin A), BOA also identified the gallidermin-related
lantibiotic Streptin [34]. Despite the experimental vali-
dation of Streptin as an active bacteriocin, little further
insight has been gained into the role of Streptin with
respect to pathogenic infection or colonization dynam-
ics [35]. Identification and subsequent experimental val-
idation of bacteriocins in important human pathogens
like Group A Streptococcus will likely yield insights into
the biology and biochemistry of pathogenic coloniza-
tion, especially given the current explosion of inter-
est in the human microbiome and probiotic disease
interventions.
Of the 1054 species with identified bacteriocins, only
11 species were from the domain Archaea out of 360
Archaea genomes in GenBank. From the 1043 bacte-
rial species with bacteriocins identified, the majority of
them are identified as either Proteobacteria or Firmicutes.
The exact breakdown of the phyla and their correspond-
ing mean function counts is shown in Table 3, while
a breakdown at the class level is shown in Table 4. It
is important to note that our finding does not imply
that most bacteriocin producing bacteria are Firmicutes
and Proteobacteria, or that bacteriocins are rare in
Archaea. It is more likely that previous research in iden-
tifying bacteriocins was biased towards the former two
phyla.
From Table 3, it is apparent that mean distribution
of gene types between phyla are very different. For
instance, Firmicutes have significantly more immunity
genes than any of the other phyla. Also, gene blocks found
in Firmicutes, Actinobacteria and Cyanobacteria have a
higher toxin gene count than other bacterial phyla. A full
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Fig. 6 A tree of all of the species with detected bacteriocins. The five inner rings show gene abundances for immunity, modifier, regulator, toxin and
transport genes. The outer ring shows the total number of bacteriocin-associated gene blocks detected for each bacterial species. This information
is available in tabular form in the supplemental material
survey of putative bacteriocin gene blocks is provided in
the supplementary data. Figure 6 shows an overview of
the distribution of putative bacteriocin blocks identified
by BOA.
Conclusions
To our knowledge, BOA is the first time a curated
data set has been established for bacteriocin context
genes. Even with seven different bacteriocin gene blocks
as a gold standard set, our method has identified sev-
eral hundred putative bacteriocin gene blocks, most of
which have not been previously annotated. We believe
that even more homologous gene blocks can be iden-
tified with a larger validated database of context genes.
Additionally, upon manual inspection of some predicted
blocks, some nearby putative ORFs appeared likely to be
involved in predicted bacteriocin biosynthesis but were
not identified by BOA. This may permit a manually
curated strategy whereby one may subjectively designate
putative context genes from a BOA-predicted bacteri-
ocin gene block and feed the more richly-annotated gene
block back into BOA as a new member of the now-
expanded gold standard set. Such an approach could serve
to iteratively extend the phylogenetic boundaries of BOA
in a controlled way each time the limits of similarity
are reached. We are currently exploring the merits of
this approach. The widespread prevalence and diversity
of bacteria having bacteriocins and their highly varied
lifestyles suggest early ancestry and a subsequent adap-
tation of these gene blocks to the specific functional
needs of the bacteria producing them. Previous studies
have shown that bacteriocin context genes tend to be in
bacteria that share an environmental niche despite phylo-
genetic disparity, suggesting that functional adaptation is
likely to be a major mechanism for bacteriocin design and
production [12].
BOA was able to identify the majority of bacteriocin
gene clusters that BAGEL identified. BOA also predicted
over seven times more bacteriocins in whole bacterial
genomes than BAGEL, including many identifiable bacte-
riocin gene blocks with experimental validation. Because
BOA encompasses a large number of taxa, the informa-
tion in BOA can also be used to explore the evolutionary
development of bacteriocin gene blocks and how different
biosynthetic loci have evolved in different clades. Finally,
BOA has assembled the first dataset that contains infor-
mation about homologous bacteriocin genes and their
associated gene clusters.
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